ArticleFrontiers in cell and developmental biology2022

MHC-II Signature Correlates With Anti-Tumor Immunity and Predicts anti-PD-L1 Response of Bladder Cancer.

Ruibin Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.